AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $892,206 | -21.6% | 19,400 | -2.0% | 0.02% | -20.0% |
| Q2 2023 | $1,137,906 | +72.4% | 19,800 | +12.5% | 0.02% | +47.1% |
| Q1 2023 | $660,000 | +131374.1% | 17,600 | -1.7% | 0.02% | +21.4% |
| Q4 2022 | $502 | -99.9% | 17,900 | -2.2% | 0.01% | -6.7% |
| Q3 2022 | $514,000 | -22.9% | 18,300 | +0.5% | 0.02% | -16.7% |
| Q2 2022 | $667,000 | -4.7% | 18,200 | +1.7% | 0.02% | +5.9% |
| Q1 2022 | $700,000 | +68.7% | 17,900 | +0.6% | 0.02% | +88.9% |
| Q4 2021 | $415,000 | +22.8% | 17,800 | 0.0% | 0.01% | +12.5% |
| Q3 2021 | $338,000 | +1.5% | 17,800 | +7.9% | 0.01% | 0.0% |
| Q2 2021 | $333,000 | +9.5% | 16,500 | -0.6% | 0.01% | 0.0% |
| Q1 2021 | $304,000 | -10.1% | 16,600 | -1.2% | 0.01% | -20.0% |
| Q4 2020 | $338,000 | +6.6% | 16,800 | -0.6% | 0.01% | -33.3% |
| Q3 2020 | $317,000 | +54.6% | 16,900 | +85.3% | 0.02% | +25.0% |
| Q2 2020 | $205,000 | -8.9% | 9,120 | -21.9% | 0.01% | +9.1% |
| Q4 2019 | $225,000 | -10.7% | 11,680 | -8.0% | 0.01% | -15.4% |
| Q3 2019 | $252,000 | -5.6% | 12,700 | -3.8% | 0.01% | 0.0% |
| Q2 2019 | $267,000 | +1.1% | 13,200 | +2.3% | 0.01% | 0.0% |
| Q1 2019 | $264,000 | +2.3% | 12,900 | -0.3% | 0.01% | -13.3% |
| Q4 2018 | $258,000 | -12.2% | 12,941 | -15.4% | 0.02% | +15.4% |
| Q3 2018 | $294,000 | +19.5% | 15,300 | -5.0% | 0.01% | +18.2% |
| Q2 2018 | $246,000 | -16.3% | 16,100 | +2.5% | 0.01% | -15.4% |
| Q1 2018 | $294,000 | +0.7% | 15,700 | +3.3% | 0.01% | 0.0% |
| Q4 2017 | $292,000 | +13.6% | 15,200 | +5.6% | 0.01% | +8.3% |
| Q3 2017 | $257,000 | -0.8% | 14,400 | -0.7% | 0.01% | -7.7% |
| Q2 2017 | $259,000 | +22.2% | 14,500 | -0.7% | 0.01% | +18.2% |
| Q1 2017 | $212,000 | -20.0% | 14,600 | +1.4% | 0.01% | -21.4% |
| Q4 2016 | $265,000 | -10.5% | 14,400 | -7.7% | 0.01% | -12.5% |
| Q3 2016 | $296,000 | – | 15,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRIESS ASSOCIATES LLC | 97,760 | $3,401,000 | 5.68% |
| Nantahala Capital Management | 1,000,000 | $34,790,000 | 1.74% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 341,294 | $11,874,000 | 1.52% |
| Portolan Capital Management | 274,889 | $9,563,000 | 0.96% |
| Quantedge Capital Pte Ltd | 121,500 | $4,227,000 | 0.85% |
| SHAKER INVESTMENTS LLC/OH | 37,117 | $1,291,000 | 0.82% |
| GLOBEFLEX CAPITAL L P | 72,253 | $2,514,000 | 0.61% |
| EAM Investors, LLC | 68,855 | $2,395,000 | 0.58% |
| Hillsdale Investment Management Inc. | 197,738 | $6,879,000 | 0.55% |
| Capital Impact Advisors, LLC | 13,835 | $481,000 | 0.44% |